Livforsakringsbolaget Skandia’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100
Closed -$25K 606
2022
Q3
$25K Sell
100
-200
-67% -$54K ﹤0.01% 434
2022
Q2
$74K Sell
300
-300
-50% -$81K 0.01% 507
2022
Q1
$199K Hold
600
0.01% 471
2021
Q4
$215K Hold
600
0.01% 484
2021
Q3
$195K Hold
600
0.01% 515
2021
Q2
$187K Hold
600
0.01% 560
2021
Q1
$191K Buy
600
+200
+50% +$64K 0.01% 476
2020
Q4
$130K Hold
400
0.01% 540
2020
Q3
$111K Hold
400
0.01% 522
2020
Q2
$97K Hold
400
0.01% 540
2020
Q1
$58K Hold
400
0.01% 586
2019
Q4
$68K Hold
400
0.01% 599
2019
Q3
$71K Hold
400
0.01% 576
2019
Q2
$104K Hold
400
0.01% 490
2019
Q1
$114K Hold
400
0.02% 461
2018
Q4
$130K Hold
400
0.02% 394
2018
Q3
$180K Sell
400
-200
-33% -$78.8K 0.02% 403
2018
Q2
$245K Buy
+600
New +$217K 0.02% 452

Other funds holding ABMD

Livforsakringsbolaget Skandia's ABMD Position: Q4 2022 in Review

Livforsakringsbolaget Skandia sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 100 shares — an estimated $25K sold.

Livforsakringsbolaget Skandia first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $245K in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Livforsakringsbolaget Skandia reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 100 Abiomed Inc shares in Q4 2022, an estimated $25K.
  • Livforsakringsbolaget Skandia first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • Livforsakringsbolaget Skandia's Abiomed Inc position peaked at $245K in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2022, filed 13 Feb 2023.